durvalumab
Imfinzi
Pharmaceutical company: AstraZeneca
NEW INDICATION & DOSAGE
Adults weighing 30 kg or more: 1,500-mg IV infusion every 4 weeks until disease progression, unacceptable toxicity, or a maximum of 24 months.
Adults weighing 30 kg or less: 20-mg/kg IV infusion every 4 weeks until disease progression, unacceptable toxicity, or a maximum of 24 months.
Released: February 2025
Nursing Drug Handbook
© 2025 Wolters Kluwer N.V., its subsidiaries and/or its licensors. All rights reserved.